Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Various ARID1A expression patterns and their clinical significance in gastric cancers.

Tytuł:
Various ARID1A expression patterns and their clinical significance in gastric cancers.
Autorzy:
Kim YB; Department of Pathology, Ajou University School of Medicine, Suwon 443-380, Republic of Korea.
Ham IH; Department of Surgery, Ajou University School of Medicine, Suwon 443-380, Republic of Korea.
Hur H; Department of Surgery, Ajou University School of Medicine, Suwon 443-380, Republic of Korea.
Lee D; Department of Pathology, Ajou University School of Medicine, Suwon 443-380, Republic of Korea. Electronic address: .
Źródło:
Human pathology [Hum Pathol] 2016 Mar; Vol. 49, pp. 61-70. Date of Electronic Publication: 2015 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Philadelphia, PA : W B Saunders
Original Publication: Philadelphia, W B. Saunders Co.
MeSH Terms:
Adenocarcinoma/*chemistry
Biomarkers, Tumor/*analysis
Nuclear Proteins/*analysis
Stomach Neoplasms/*chemistry
Transcription Factors/*analysis
Adaptor Proteins, Signal Transducing/analysis ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Adult ; Aged ; Aged, 80 and over ; Biopsy ; Cell Differentiation ; DNA-Binding Proteins ; Disease-Free Survival ; Down-Regulation ; Female ; Gastrectomy ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Middle Aged ; MutL Protein Homolog 1 ; Predictive Value of Tests ; Proportional Hazards Models ; Ribosomal Protein S6 Kinases/analysis ; Risk Factors ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Time Factors ; Treatment Outcome ; Young Adult
Contributed Indexing:
Keywords: AKT pathway; ARID1A; Gastric cancer; Immunohistochemistry; Prognosis
Substance Nomenclature:
0 (ARID1A protein, human)
0 (Adaptor Proteins, Signal Transducing)
0 (Biomarkers, Tumor)
0 (DNA-Binding Proteins)
0 (MLH1 protein, human)
0 (Nuclear Proteins)
0 (Transcription Factors)
EC 2.7.11.1 (Ribosomal Protein S6 Kinases)
EC 3.6.1.3 (MutL Protein Homolog 1)
Entry Date(s):
Date Created: 20160131 Date Completed: 20160606 Latest Revision: 20201209
Update Code:
20240104
DOI:
10.1016/j.humpath.2015.10.008
PMID:
26826411
Czasopismo naukowe
AT-rich interactive domain 1A (ARID1A) is frequently mutated in gastric cancers, and loss of ARID1A expression is considered a poor prognostic factor in various cancers. However, in practice, ARID1A shows various expression patterns, and our understanding of its significance is limited. We performed immunohistochemistry for ARID1A, MLH1, and pS6 using whole tissue blocks of 350 gastric cancers and classified the ARID1A expression as follows: retained (63.7%), reduced (17.7%), complete loss (14.9%), and partial loss (3.7%). Complete/partial loss was more common in poorly differentiated histology (P < .001), and reduced or complete loss of ARID1A was frequent in cases with MLH1 loss (P < .001). The ARID1A-reduced group showed only slightly inferior disease-free survival (DFS; P = .254) and overall survival (OS; P = .377) compared to those of the ARID1A-retained group, whereas the group with complete loss showed significantly worse DFS (hazard ratio [HR], 1.732; P = .015) and OS (HR, 1.751; P = .013). Worse DFS (HR, 2.672; P = .005) and OS (HR, 2.531; P = .002) were also noted in the group with partial loss. High expression of pS6 was observed more frequently in groups showing altered ARID1A expression patterns (P < .001). In conclusion, reduced ARID1A expression is not a major prognostic determinant, although it may lead to AKT pathway activation. Tumor cells lacking ARID1A expression may influence the prognosis even if they constitute only a small proportion of the tumor sample. Our data provide an enhanced roadmap for understanding ARID1A with implications for future research and therapeutics.
(Copyright © 2015 Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies